Results 1 to 10 of about 32,295 (302)

Pharmacotherapy for treatment-resistant schizophrenia

Neuropsychiatric Disease and Treatment, 2011
Meghan E Mcilwain1,2, Jeff Harrison1, Amanda J Wheeler1,3, Bruce R Russell1,21School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; 2Centre for Brain Research, Faculty of Medical and Health Sciences ...
Meghan E Mcilwain, Jeff Harrison, Amanda J Wheeler, et al   +3 more
doaj   +7 more sources

Treatment-resistant schizophrenia: How far have we traveled?

Frontiers in Psychiatry, 2022
Treatment-resistant schizophrenia is a lack of adequate response to antipsychotic medications resulting in incomplete functional and social recovery from the illness.
Ambu Pandey, Kamal Narayan Kalita
doaj   +3 more sources

The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS) [PDF]

Frontiers in Psychiatry, 2019
Schizophrenia is composed of a heterogeneous group of patient segments. Our current notion of the heterogeneity in schizophrenia is based on patients presenting with diverse disease symptom phenotypes, risk factors, structural and functional neuropathology, and a mixed range of expressed response to treatment.
Bruce J Kinon
exaly   +4 more sources

Distinct subcortical neuroanatomic profiles of treatment-resistant schizophrenia: structural magnetic resonance imaging study [PDF]

BJPsych Open
Background Understanding the neuroanatomical correlates of treatment response in schizophrenia is crucial for improving clinical stratification and clarifying underlying pathophysiological mechanisms.
Ibrahim Sungur, Simay Selek, Kaan Keskin, Asli Ceren Hinc, Furkan Yazici, Elif Ozge Aktas, Yigit Erdogan, Omer Kitis, Ali Saffet Gonul   +8 more
doaj   +2 more sources

Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT

Frontiers in Psychiatry, 2023
IntroductionAmong treatment-resistant depression (TRD), we identified anergic-anhedonic clinical presentations (TRAD) as putatively responsive to pro-dopaminergic strategies.
Ludovic Christophe Dormegny-Jeanjean, Ludovic Christophe Dormegny-Jeanjean, Ludovic Christophe Dormegny-Jeanjean, Clément de Billy, Clément de Billy, Clément de Billy, Olivier Mainberger, Olivier Mainberger, Olivier Mainberger, Sébastien Weibel, Sébastien Weibel, Sébastien Weibel, Benoit Schorr, Benoit Schorr, Benoit Schorr, Alexandre Obrecht, Alexandre Obrecht, Lionel Landré, Fabrice Berna, Fabrice Berna, Jean-Baptiste Causin, Jean-Baptiste Causin, Jean-Baptiste Causin, Frederic Blanc, Frederic Blanc, Vlad Danila, Vlad Danila, Mihaela Tomsa, Mihaela Tomsa, Geraldine Pfleger, Geraldine Pfleger, Camille Meyer, Camille Meyer, Camille Meyer, Ilia Humbert, Ilia Humbert, Ilia Humbert, Hervé Javelot, Hervé Javelot, Guillaume Meyer, Guillaume Meyer, Gilles Bertschy, Gilles Bertschy, Gilles Bertschy, Jack Rene Foucher, Jack Rene Foucher, Jack Rene Foucher, Jack Rene Foucher   +47 more
doaj   +1 more source

A case report of inhibition and severe desnutrition: negative symptoms in resistant schizophrenia

European Psychiatry, 2022
Introduction The appearance of inhibitory symptoms encompassed in what are known as negative symptoms is part of the usual symptoms of schizophrenia.
P. Coucheiro Limeres, B. Díez Valle, A. Cerame, C. Lozano Serrano, E. Navas Collado   +4 more
doaj   +1 more source

Cognition in Patients with Schizophrenia: Interplay between Working Memory, Disorganized Symptoms, Dissociation, and the Onset and Duration of Psychosis, as Well as Resistance to Treatment

Biomedicines, 2023
Schizophrenia is traditionally associated with the presence of psychotic symptoms. In addition to these, cognitive symptoms precede them and are present during the entire course of the schizophrenia process.
Georgi Panov, Silvana Dyulgerova, Presyana Panova   +2 more
doaj   +1 more source

Gender-associated role in patients with schizophrenia. Is there a connection with the resistance?

Frontiers in Psychiatry, 2022
Schizophrenia is a chronic mental illness observed with equal prevalence in different cultures and ethnic groups. The clinical picture relates to behavior and social adaptation.
Georgi Panov
doaj   +1 more source

Dissociative Model in Patients With Resistant Schizophrenia

Frontiers in Psychiatry, 2022
BackgroundSchizophrenia is a severe mental illness in which, despite the growing number of antipsychotics from 30 to 50% of patients remain resistant to treatment. Many resistance factors have been identified.
Georgi Panov
doaj   +1 more source

Is It Time for a Paradigm Shift in the Treatment of Schizophrenia? The Use of Inflammation-Reducing and Neuroprotective Drugs—A Review

Brain Sciences, 2023
Comprehending the pathogenesis of schizophrenia represents a challenge for global mental health. To date, although it is evident that alterations in dopaminergic, serotonergic, and glutamatergic neurotransmission underlie the clinical expressiveness of ...
Antonino Messina, Carmen Concerto, Alessandro Rodolico, Antonino Petralia, Filippo Caraci, Maria Salvina Signorelli   +5 more
doaj   +1 more source